AI in Medicine News ・ 💊 Drug discovery and clinical trials

Swiss VC Redalpine Raises $250 Million for A.I., Robotics and Biotech

www.trendingtopics.eu · 11/10 07:00 UTC

Swiss venture firm Redalpine has closed its oversubscribed eighth early-stage fund at $250 million. The first investments are Enact, Helical and Arlequin AI.

Read the original (www.trendingtopics.eu)

See it in the digest → ・ See this issue →